Last update 16 May 2025

NTB-3119M

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms-
Target
DprE1
Action
inhibitors
Mechanism
DprE1 inhibitors(FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
TuberculosisPulmonary Tuberculosis
Inactive Indication-
Originator Organization
Institute of Materia MedicaInstitute of Materia Medica
Active Organization
Institute of Materia MedicaInstitute of Materia MedicaQingdao Guofeng Group Huayang Parmaceutical Co. Ltd.Qingdao Guofeng Group Huayang Parmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NTB-3119M
CTR20251263
/ RecruitingPhase 1
在中国健康参与者中评价单次与多次口服NTB-3119M片剂量递增的安全性、耐受性、药代动力学特征及食物对药代动力学影响的I期临床试验
[Translation] A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and the effect of food on the pharmacokinetics of single and multiple oral escalating doses of NTB-3119M tablets in healthy Chinese participants
100 Clinical Results associated with NTB-3119M
Login to view more data
100 Translational Medicine associated with NTB-3119M
Login to view more data
100 Patents (Medical) associated with NTB-3119M
Login to view more data
100 Deals associated with NTB-3119M
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
TuberculosisPhase 1
China
Qingdao Guofeng Group Huayang Parmaceutical Co. Ltd.Qingdao Guofeng Group Huayang Parmaceutical Co. Ltd.
13 Apr 2025
TuberculosisPhase 1
China
Institute of Materia MedicaInstitute of Materia Medica
13 Apr 2025
Pulmonary TuberculosisPreclinical
China
Institute of Materia MedicaInstitute of Materia Medica
26 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free